Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

establishment labs holdings inc - ESTA

ESTA

Close Chg Chg %
58.70 -0.39 -0.66%

Closed Market

58.31

-0.39 (0.66%)

Volume: 279.44K

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Trade Now

Company Overview: establishment labs holdings inc - ESTA

ESTA Key Data

Open

$58.47

 Day Range

56.98 - 59.02

52 Week Range

26.56 - 83.31

 Market Cap

$1.71B

Shares Outstanding

29.32M

 Public Float

26.47M

Beta

1.08

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$1.74

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

510.34K

  

ESTA Performance

1 Week
 
 5.42%
 
1 Month
 
 -17.19%
 
3 Months
 
 -15.30%
 
1 Year
 
 80.53%
 
5 Years
 
 -11.79%
 

ESTA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About establishment labs holdings inc - ESTA

Establishment Labs Holdings, Inc. engages in the manufacturing and marketing of medical devices for aesthetic and reconstructive plastic surgery. Its brands include Motiva Implants, SilkSurface, SmoothSilk, VelvetSurface, ProgressiveGel, TrueMonobloc, BluSeal, Divina, Ergonomix, Ergomonix2, Ergonomix2 Diamond, Mia Femtech, MotivaImagine, GEM, Zen, Preservé, etc. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Austin, TX.

ESTA At a Glance

Establishment Labs Holdings, Inc.
11401 Century Oaks Terrace
Austin, Texas 78758
Phone 1-800-924-5072 Revenue 211.08M
Industry Medical Specialties Net Income -51,064,000.00
Sector Health Technology 2025 Sales Growth 27.135%
Fiscal Year-end 12 / 2026 Employees 1,004
View SEC Filings

ESTA Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 10.227
Price to Book Ratio 90.701
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -82.274
Enterprise Value to Sales 11.122
Total Debt to Enterprise Value 0.113

ESTA Efficiency

Revenue/Employee 210,235.06
Income Per Employee -50,860.558
Receivables Turnover 2.724
Total Asset Turnover 0.60

ESTA Liquidity

Current Ratio 3.043
Quick Ratio 1.996
Cash Ratio 0.92

ESTA Profitability

Gross Margin 69.315
Operating Margin -18.481
Pretax Margin -27.489
Net Margin -24.192
Return on Assets -14.507
Return on Equity -133.253
Return on Total Capital -17.73
Return on Invested Capital -18.543

ESTA Capital Structure

Total Debt to Total Equity 1,123.145
Total Debt to Total Capital 91.824
Total Debt to Total Assets 74.046
Long-Term Debt to Equity 1,063.159
Long-Term Debt to Total Capital 86.92
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Establishment Labs Holdings Inc - ESTA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
161.70M 165.15M 166.03M 211.08M
Sales Growth
+27.64% +2.13% +0.53% +27.14%
Cost of Goods Sold (COGS) incl D&A
55.11M 58.17M 56.50M 64.77M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.17M 4.88M 7.58M 10.47M
Depreciation
2.97M 3.68M 5.48M 7.17M
Amortization of Intangibles
1.20M 1.20M 2.10M 3.30M
COGS Growth
+33.50% +5.57% -2.88% +14.63%
Gross Income
106.60M 106.98M 109.53M 146.31M
Gross Income Growth
+24.81% +0.36% +2.38% +33.58%
Gross Profit Margin
+65.92% +64.78% +65.97% +69.32%
2022 2023 2024 2025 5-year trend
SG&A Expense
146.25M 172.00M 159.51M 185.32M
Research & Development
20.27M 26.43M 19.71M 20.25M
Other SG&A
125.98M 145.57M 139.81M 165.07M
SGA Growth
+32.30% +17.61% -7.26% +16.18%
Other Operating Expense
- - - -
-
Unusual Expense
- - 18.32M 543.00K
-
EBIT after Unusual Expense
(57.97M) (65.03M) (49.99M) (39.55M)
Non Operating Income/Expense
(3.09M) 1.84M (13.81M) 6.79M
Non-Operating Interest Income
87.00K 1.02M 1.48M 423.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
11.76M 15.39M 20.83M 25.26M
Interest Expense Growth
+29.77% +30.89% +35.31% +21.25%
Gross Interest Expense
11.76M 15.39M 20.83M 25.26M
Interest Capitalized
- - - -
-
Pretax Income
(72.82M) (78.58M) (84.63M) (58.02M)
Pretax Income Growth
-83.38% -7.91% -7.69% +31.44%
Pretax Margin
-45.04% -47.58% -50.97% -27.49%
Income Tax
2.39M (81.00K) (32.00K) (6.96M)
Income Tax - Current - Domestic
114.00K 297.00K 183.00K 112.00K
Income Tax - Current - Foreign
2.19M 3.33M 1.96M 2.37M
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
86.00K (3.71M) (2.18M) (9.44M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(75.21M) (78.50M) (84.60M) (51.06M)
Minority Interest Expense
- - - -
-
Net Income
(75.21M) (78.50M) (84.60M) (51.06M)
Net Income Growth
-82.82% -4.38% -7.76% +39.64%
Net Margin Growth
-46.51% -47.53% -50.95% -24.19%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(75.21M) (78.50M) (84.60M) (51.06M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(75.21M) (78.50M) (84.60M) (51.06M)
EPS (Basic)
-3.0751 -3.0665 -3.0039 -1.724
EPS (Basic) Growth
-79.19% +0.28% +2.04% +42.61%
Basic Shares Outstanding
24.46M 25.60M 28.16M 29.62M
EPS (Diluted)
-3.0751 -3.0665 -3.0039 -1.724
EPS (Diluted) Growth
-79.19% +0.28% +2.04% +42.61%
Diluted Shares Outstanding
24.46M 25.60M 28.16M 29.62M
EBITDA
(35.49M) (60.14M) (42.41M) (28.53M)
EBITDA Growth
-68.72% -69.47% +29.48% +32.72%
EBITDA Margin
-21.95% -36.42% -25.54% -13.52%

Snapshot

Average Recommendation BUY Average Target Price 89.778
Number of Ratings 9 Current Quarters Estimate -0.258
FY Report Date 06 / 2026 Current Year's Estimate -1.008
Last Quarter’s Earnings -0.385 Median PE on CY Estimate N/A
Year Ago Earnings -1.72 Next Fiscal Year Estimate 0.199
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 8 8
Mean Estimate -0.26 -0.27 -1.01 0.20
High Estimates -0.11 -0.02 -0.20 0.97
Low Estimate -0.33 -0.35 -1.29 -0.33
Coefficient of Variance -32.69 -41.92 -36.18 182.79

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 8
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Establishment Labs Holdings Inc - ESTA

Date Name Shares Transaction Value
Apr 2, 2026 Ann Custin Director 21,732 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $56.78 per share 1,233,942.96
Apr 2, 2026 Bryan Slotkin Director 30,256 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $56.78 per share 1,717,935.68
Apr 2, 2026 Nicholas S. Lewin Director 1,077,315 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $56.78 per share 61,169,945.70
Apr 2, 2026 Leslie G. Gillin Director 16,044 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $56.78 per share 910,978.32
Apr 2, 2026 Edward J. Schutter Director 138,602 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $56.78 per share 7,869,821.56
Mar 25, 2026 Juan José Chacón-Quirós Director 1,223,779 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $62.62 per share 76,633,040.98
Mar 25, 2026 Juan José Chacón-Quirós Director 1,223,579 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $63.01 per share 77,097,712.79
Mar 25, 2026 Juan José Chacón-Quirós Director 1,225,292 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $61.7 per share 75,600,516.40
Mar 25, 2026 Juan José Chacón-Quirós Director 1,226,079 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $60.23 per share 73,846,738.17
Mar 25, 2026 Juan José Chacón-Quirós Director 1,257,504 Other acquisition or disposition 0.00
Mar 25, 2026 Juan José Chacón-Quirós Director 45,193 Other acquisition or disposition 0.00
Nov 11, 2025 JW Asset Management LLC 3,075,194 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $65 per share 199,887,610.00
Aug 12, 2025 Peter Caldini Chief Executive Officer; Director 35,245 Open market or private purchase of non-derivative security Non-derivative transaction at $35.2 per share 1,240,624.00
Apr 7, 2025 S. Ross Mansbach 15,238 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 S. Ross Mansbach 13,998 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 Peter Caldini Int Chief Executive Officer 30,333 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 Rajbir S. Denhoy Chief Financial Officer 19,716 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 Rajbir S. Denhoy Chief Financial Officer 23,348 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Establishment Labs Holdings Inc in the News